Fluorescent risedronate analogue 800CW-pRIS improves tooth extraction-associated abnormal wound healing in zoledronate-treated mice.
Hiroko OkawaTakeru KondoAkishige HokugoPhilip CherianOskar SundbergJesus J CampagnaBoris A KashemirovVarghese JohnShuting SunFrank H EbetinoCharles E McKennaIchiro NishimuraPublished in: Communications medicine (2022)
Topical pre-treatment with 800CW-RIS in DNV is a promising approach to prevent the complication of abnormal oral wound healing associated with BRONJ while retaining the anti-resorptive benefit of legacy N-BP in appendicular or vertebrate bones.